Filing Details

Accession Number:
0001209191-17-021207
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-16 19:31:04
Reporting Period:
2017-03-14
Filing Date:
2017-03-16
Accepted Time:
2017-03-16 19:31:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1621328 Peony K Yu C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-14 4,651 $25.13 234,246 No 4 S Direct
Common Stock Disposition 2017-03-14 3,200 $25.80 231,046 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices ranging from $24.9125 to $25.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices ranging from $25.50 to $26.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.